🔬
Foundation Sciences · Biochemistry

DNA Repair Mechanisms

⏱️ 45–60 minutes read 📖 Biochemistry

Mismatch, nucleotide excision, base excision and double-strand break repair (HR/NHEJ).

📌 Learning Objectives

  • Describe the key principles of dna repair mechanisms.
  • Explain the clinical relevance of dna repair mechanisms.
  • Recognise common conditions linked to dna repair mechanisms in MLA-style scenarios.

📋 Overview

Mismatch, nucleotide excision, base excision and double-strand break repair (HR/NHEJ). This topic integrates with pathology, pharmacology and clinical medicine and is frequently tested in UK medical school exams and the MLA.

🔬 Basic Science

Mismatch, nucleotide excision, base excision and double-strand break repair (HR/NHEJ). Detailed mechanisms, regulation and molecular interactions underpin both normal physiology and disease.

🏥 Clinical Relevance

PARP inhibitors (olaparib) in BRCA-mutant cancers; immunotherapy in MMR-deficient tumours.

🧪 Investigations

Relevant laboratory tests, imaging or histological examination are used as appropriate to the clinical context.

💊 Management

Management is condition-specific; principles include addressing the underlying biochemical/structural derangement, supportive care and targeted therapy where available.

Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.

🎯 MLA High-Yield Notes & Quick Revision
High-yield topic for the UK MLA — frequently appears in SBA questions linking biochemistry concepts to clinical presentations and management decisions.
Applying biomedical science to clinical practice Diagnosis and investigation Pathophysiology of common conditions
  • Mismatch, nucleotide excision, base excision and double-strand break repair (HR/NHEJ).
Exam Pearls
⭐ High Yield
MMR defects → Lynch syndrome
NER defects → xeroderma pigmentosum
BRCA1/2 in homologous recombination
PARP inhibitors synthetic lethality
💡 Clinical Pearl
: PARP inhibitors (olaparib) in BRCA-mutant cancers; immunotherapy in MMR-deficient tumours.
⚠️ Exam Tip — Common Mistakes
Confusing dna repair mechanisms with related but distinct mechanisms.
Memorising pathways without linking to clinical disease.
🔑 Key Facts
MMR defects → Lynch syndrome
NER defects → xeroderma pigmentosum
BRCA1/2 in homologous recombination
PARP inhibitors synthetic lethality
📚 References
  1. BMJ Best Practice
  2. Robbins Basic Pathology
  3. Lippincott Illustrated Reviews: Biochemistry
  4. Wheater's Functional Histology
  5. NICE guidance where applicable.

Further Resources

Medical Portfolio & Career Development

Build a professional portfolio website for applications, audits, teaching, research and career progression.

CVtoWebsite.com →